Sugi Predict

Sugi Predict / Compounds / SCHEMBL6484033

SCHEMBL6484033

SCHEMBL6484033

CCN(CC)c1ccc(CCCc2ccc(Nc3c(C(=O)O)cccc3[N+](=O)[O-])cc2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 6/20 0.43
▸ MEN1 O00255 4/20 0.43
▸ ALDH1A1 P00352 3/20 0.43
▸ POLB P06746 1/20 0.43
▸ ABCG2 Q9UNQ0 1/20 0.42
▸ PLK1 P53350 1/20 0.41
▸ PLK3 Q9H4B4 1/20 0.41
▸ GHSR Q92847 1/20 0.41
▸ TSHR P16473 1/20 0.41
▸ NPC1 O15118 3/20 0.40
▸ RAB9A P51151 3/20 0.40
▸ NOX1 Q9Y5S8 1/20 0.40
▸ CDK2 P24941 1/20 0.39
▸ KDM1A O60341 1/20 0.39
▸ MAPT P10636 4/20 0.39
▸ SMN1; SMN2 Q16637 3/20 0.39
▸ LMNA P02545 3/20 0.39
▸ EIF4A1 P60842 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16862346 0.82 KMT2A (0.56) KMT2AMEN1ALDH1A1POLBABCG2
SCHEMBL6474913 0.78 MEN1 (0.55) KMT2AMEN1ALDH1A1PLK1PLK3
SCHEMBL6475576 0.78 MAPT (0.46) KMT2AMEN1ALDH1A1POLBABCG2
SCHEMBL6481662 0.78 CTSV (0.58) KMT2AMEN1ALDH1A1TSHRNPC1
SCHEMBL12172798 0.76 POLB (0.61) KMT2AMEN1ALDH1A1POLBGHSR
SCHEMBL6474951 0.76 MEN1 (0.61) KMT2AMEN1ALDH1A1POLBTSHR
SCHEMBL2293244 0.76 CXCR2 (0.59) KMT2AMEN1ALDH1A1POLBTSHR
SCHEMBL6475590 0.76 KMT2A (0.50) KMT2AMEN1ALDH1A1POLBTSHR
SCHEMBL6474976 0.74 CDK2 (0.44) KMT2AMEN1ALDH1A1POLBABCG2
SCHEMBL6484606 0.74 RARB (0.50) KMT2AMEN1ALDH1A1POLBNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6972287-B1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits PFIZER INC. (US) 2005-12-06 — — US claimed
EP-1225886-A2 METHOD OF INHIBITING AMYLOID PROTEIN AGGREGATION AND IMAGING AMYLOID DEPOSITS WARNER-LAMBERT COMPANY (US) 2002-07-31 — — EP claimed
WO-2000076489-A2 METHOD OF INHIBITING AMYLOID PROTEIN AGGREGATION AND IMAGING AMYLOID DEPOSITS WARNER-LAMBERT COMPANY (US) 2000-12-21 — — WO claimed
US-6972287-B1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits PFIZER INC. (US) 2005-12-06 — — US disclosed
US-20040220235-A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits AUGELLI-SZAFRAN CORINNE ELIZAB (US) 2004-11-04 — — US disclosed
EP-1225886-A2 METHOD OF INHIBITING AMYLOID PROTEIN AGGREGATION AND IMAGING AMYLOID DEPOSITS WARNER-LAMBERT COMPANY (US) 2002-07-31 — — EP disclosed
WO-2000076489-A2 METHOD OF INHIBITING AMYLOID PROTEIN AGGREGATION AND IMAGING AMYLOID DEPOSITS WARNER-LAMBERT COMPANY (US) 2000-12-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040220235-A1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits APP, PSEN1, BACE1 KMT2A 4729/4885MEN1 474/4885ALDH1A1 2945/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.